Reactivity of imidazolidin-4-one derivatives of primaquine: implications for prodrug design

Chambel, Paula; Capela, Rita; Lopes, Francisca; Iley, Jim; Morais, Jose; Gouveia, Luıs; Gomes, Jose R. B.; Gomes, Paula and Moreira, Rui (2006). Reactivity of imidazolidin-4-one derivatives of primaquine: implications for prodrug design. Tetrahedron, 62(42) pp. 9883–9891.

DOI: https://doi.org/10.1016/j.tet.2006.08.026

Abstract

In contrast to peptide-based imidazolidin-4-ones, those synthesized from N-(alpha-aminoacyl) derivatives of the antimalarial drug, primaquine and ketones are unexpectedly stable in pH 7.4 at 37 C. The kinetics of hydrolysis of primaquine-based imidazolidin-4-ones were investigated in the pH range 0.3–13.5 at 60 C. The hydrolysis to the parent alpha-aminoacylprimaquine is characterized by sigmoidal shaped pH–rate profiles, reflecting the spontaneous decomposition of both unionized and protonated (at N-1) forms of the imidazolidin-4-one. The kinetically determined pKa values are ca. 3.6–4.0, i.e. 4 pKa units lower than those of amino acid amides, thus implying that hydrolysis of imidazolidin-4-ones at pH 7.4 involves the unionized form. Reactivity of this form decreases with the steric crowding of the amino acid alpha-substituent. In contrast, the rate constant for the spontaneous decomposition of the unionized form increases sharply for
imidazolidin-4-ones derived from cyclic ketones, an observation that can be explained by the I-strain (internal strain) effect. These results are consistent with a mechanism of hydrolysis involving an SN1-type unimolecular cleavage of the imidazolidin-4-one C2–N3 bond with departure of an amide-leaving group. The mechanism for the decomposition of the protonated imidazolidin-4-one is likely to involve an amide-carbonyl oxygen protonated species, followed by the C2–N3 bond scission, as supported by computational studies. The results herein presented suggest that imidazolidin-4-ones derived from simple N-alkyl alpha-aminoamides are too stable and therefore may be useful as slow drug release prodrugs.

Viewing alternatives

Metrics

Public Attention

Altmetrics from Altmetric

Number of Citations

Citations from Dimensions
No digital document available to download for this item

Item Actions

Export

About